These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
814 related articles for article (PubMed ID: 33017027)
1. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes. Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027 [TBL] [Abstract][Full Text] [Related]
2. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients. Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009 [TBL] [Abstract][Full Text] [Related]
3. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer. Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059 [TBL] [Abstract][Full Text] [Related]
4. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer. He M; Hu C; Deng J; Ji H; Tian W World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547 [TBL] [Abstract][Full Text] [Related]
5. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma. Han C; Zhang C; Wang H; Li K; Zhao L BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel ubiquitination related gene signature for patients with breast cancer. Zheng Y; Lu W; Chen B; Zhao K Medicine (Baltimore); 2022 Sep; 101(37):e30598. PubMed ID: 36123926 [TBL] [Abstract][Full Text] [Related]
7. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
8. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321 [No Abstract] [Full Text] [Related]
9. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study. Qian JX; Yu M; Sun Z; Jiang AM; Long B Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of prognosis-associated DNA repair gene signatures in colorectal cancer. Song D; Zhang D; Chen S; Wu J; Hao Q; Zhao L; Ren H; Du N Sci Rep; 2022 Apr; 12(1):6946. PubMed ID: 35484177 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA-based signatures to improve prognostic prediction of breast cancer. Zhang Y; Wang Y; Tian G; Jiang T Medicine (Baltimore); 2020 Oct; 99(40):e22203. PubMed ID: 33019395 [TBL] [Abstract][Full Text] [Related]
12. Identification of a combined apoptosis and hypoxia gene signature for predicting prognosis and immune infiltration in breast cancer. Ren X; Cui H; Wu J; Zhou R; Wang N; Liu D; Xie X; Zhang H; Liu D; Ma X; Dang C; Kang H; Lin S Cancer Med; 2022 Oct; 11(20):3886-3901. PubMed ID: 35441810 [TBL] [Abstract][Full Text] [Related]
13. Patient-Level DNA Damage and Repair Pathway Profiles and Prognosis After Prostatectomy for High-Risk Prostate Cancer. Evans JR; Zhao SG; Chang SL; Tomlins SA; Erho N; Sboner A; Schiewer MJ; Spratt DE; Kothari V; Klein EA; Den RB; Dicker AP; Karnes RJ; Yu X; Nguyen PL; Rubin MA; de Bono J; Knudsen KE; Davicioni E; Feng FY JAMA Oncol; 2016 Apr; 2(4):471-80. PubMed ID: 26746117 [TBL] [Abstract][Full Text] [Related]
14. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
16. PANoptosis-related molecular clustering and prognostic signature associated with the immune landscape and therapy response in breast cancer. Cao Y; Guan L; Yang L; Wei C Medicine (Baltimore); 2024 Sep; 103(37):e39511. PubMed ID: 39287311 [TBL] [Abstract][Full Text] [Related]
17. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma. Xue Y; Li J; Lu X Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760 [TBL] [Abstract][Full Text] [Related]
18. A seven-DNA methylation signature as a novel prognostic biomarker in breast cancer. Tao C; Luo R; Song J; Zhang W; Ran L J Cell Biochem; 2020 Mar; 121(3):2385-2393. PubMed ID: 31646666 [TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer. Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W Gene; 2020 Dec; 762():144974. PubMed ID: 32707305 [TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of autophagy-related prognostic genes in breast cancer. Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]